Fig. 6.
Cooperative effects of CFI-400945 and seliciclib treatments. (A) Schematic of the functional relationship between supernumerary centrosomes and multipolar mitosis. (B) Effects of combination therapy of PLK4 antagonism (with CFI-400945) and CDK2 inhibition (with seliciclib) on growth of ED1 murine and Hop62 human lung cancer cells.